Impact of the Microbiome on the Efficacy of Radiation Therapy
微生物组对放射治疗疗效的影响
基本信息
- 批准号:10001011
- 负责人:
- 金额:$ 35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffectAnimalsAntibiotic TherapyAntibioticsAntibodiesAntifungal AgentsAspergillusAsthmaBacteriaBreast Cancer ModelBreast Cancer PatientBreast Cancer TreatmentCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCancer EtiologyCandida tropicalisCessation of lifeChemotherapy and/or radiationChronicCommunitiesCyclophosphamideDNA DamageDataDendritic CellsDevelopmentDiagnosisDiseaseDoseEcosystemEffectivenessEnzyme-Linked Immunosorbent AssayFlow CytometryFosteringGeneticImmuneImmune responseImmune systemImmunohistochemistryImmunosuppressionInflammationInflammatory ResponseInterferon Type IIInterleukin-4IntestinesIonizing radiationKineticsLeadMalignant NeoplasmsMediatingMusNatureNorth AmericaOrganismPathway interactionsPatientsPlayPopulationRadiationRadiation therapyRegulationResearchResearch ProposalsRoleSaccharomyces cerevisiaeScheduleShapesSolid NeoplasmT-LymphocyteTestingTherapeuticTumor ImmunityTumor-infiltrating immune cellsWomanWorkanti-canceranti-tumor immune responsebacteriomebasechemotherapycommensal bacteriadysbiosisfungal microbiotafungusgut bacteriagut microbiotaimmunogenic cell deathin vivoinsightirradiationmacrophagemalignant breast neoplasmmicrobiomemouse modelmycobiomeneoplastic cellnoveloxaliplatinprogramsradiation effectradiation responseresponsetumortumor growth
项目摘要
PROJECT SUMMARY
Breast cancer remains the most common cancer in North America and the second leading cause of cancer death
in women. Radiation therapy (RT) plays an integral part in the treatment of breast cancer with more than half of
all breast cancer patients receiving radiation sometime during the course of their treatment. The conventional
view of RT has largely focused on the effect of RT on the tumor cells themselves. However, recent studies have
demonstrated a critical role for the immune system in determining the response of tumors to RT. Further, multiple
studies have identified the bacterial and fungal microbiomes as key regulators of systemic immune responses
in various in states of inflammation including post-chemotherapy immunogenic cell death and asthma
respectively. The microbiome consists of trillions of organisms and a multitude of different species that can
either support or suppress an ongoing immune response and our preliminary data suggests that targeting
intestinal bacteria reduces the efficacy of RT whereas targeting gut fungi can enhance the efficacy of RT. The
objective of this research proposal is to address the mechanism(s) by which intestinal bacteria and fungi shape
the response to RT. The proposal tests the hypothesis that the composition of the bacterial and fungal
microbiome regulates RT-induced immune responses and that the efficacy of RT can be enhanced in vivo by
targeting specific species with the fungal microbiome. To evaluate this hypothesis, the following Aims are
proposed: Aim 1: Characterize the effect of antibiotic- or antifungal-induced intestinal dysbiosis on the efficacy
of radiation and chemotherapy; Aim 2: Define immune mechanism(s) of bacterial and fungal microbiota
regulation of tumor responses to RT; and Aim 3: Examine the role of specific intestinal fungi in modulating the
efficacy of RT. We will accomplish these aims using focal RT delivered with an advanced small animal irradiator
in a murine model of breast cancer and studying the effects of RT in the setting of bacterial or fungal dysbiosis
using a combination of flow cytometry, immunohistochemistry, quantitative PCR and ELISA to determine the
changes in the immune profile of tumors. We will also determine the role of specific fungal species in mediating
the RT-mediated anti-tumor immune response. The significance of this research is that it will provide insights
into the tumor immune responses to radiation that may lead to new microbiome-based therapies for the treatment
of breast cancer and the multiple other solid tumors in which RT plays an integral therapeutic role.
项目总结
乳腺癌仍然是北美最常见的癌症,是癌症死亡的第二大原因
在女人身上。放射治疗(RT)在乳腺癌的治疗中发挥着不可或缺的作用,超过一半的患者
所有乳腺癌患者在治疗过程中都会接受放射治疗。传统的
放射治疗的观点主要集中在放射治疗对肿瘤细胞本身的影响。然而,最近的研究表明
证明了免疫系统在决定肿瘤对RT的反应中起着关键作用。此外,还有多个
研究已经确定细菌和真菌微生物群是系统免疫反应的关键调节因素。
处于不同的炎症状态,包括化疗后免疫原性细胞死亡和哮喘
分别进行了分析。微生物群由数以万亿计的有机体和许多不同的物种组成,这些物种可以
支持或抑制正在进行的免疫反应,我们的初步数据表明,靶向
肠道细菌降低了RT的疗效,而靶向肠道真菌可以增强RT的疗效。这个
本研究建议的目的是探讨肠道细菌和真菌形成的机制(S)
对RT的反应。这项提议检验了细菌和真菌的组成
微生物组调节RT诱导的免疫反应,体内RT的有效性可以通过以下方式增强
以真菌微生物群为目标的特定物种。为了评估这一假设,以下目标是
建议:目的1:表征抗生素或抗真菌所致的肠道菌群失调对疗效的影响
目标2:确定细菌和真菌微生物区系的免疫机制(S)
调节肿瘤对RT的反应;以及目标3:检查特定肠道真菌在调节肿瘤对RT的反应中的作用
放射治疗的疗效。我们将使用先进的小动物照射器提供的焦点RT来实现这些目标
在小鼠乳腺癌模型中,研究RT在细菌或真菌失调环境中的作用
采用流式细胞术、免疫组织化学、定量聚合酶链式反应和酶联免疫吸附试验相结合的方法检测
肿瘤免疫状况的变化。我们还将确定特定真菌物种在调节
RT介导的抗肿瘤免疫反应。这项研究的意义在于,它将提供
肿瘤对辐射的免疫反应,这可能导致基于微生物组的新疗法的治疗
在乳腺癌和多种其他实体肿瘤中,RT在其中发挥着不可或缺的治疗作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen L. Shiao其他文献
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures
具有三级淋巴结构的三阴性乳腺癌中免疫检查点阻断反应的空间转录组学分析
- DOI:
10.1016/j.isci.2025.112808 - 发表时间:
2025-07-18 - 期刊:
- 影响因子:4.100
- 作者:
Richard H. Mebane;Teia Noel;Nathan Ing;Kenneth H. Gouin;Aagam Shah;David Zitser;Andrew Martinez;Gaorav Gupta;Sandra Demaria;Lorenzo Galluzzi;Alice Ho;Heather McArthur;Stephen L. Shiao;Simon.R.V. Knott - 通讯作者:
Simon.R.V. Knott
Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy
- DOI:
10.1186/s40959-025-00361-2 - 发表时间:
2025-07-03 - 期刊:
- 影响因子:3.200
- 作者:
Jean Philippe Nesseler;Katrina D. Silos;Olivia Peony;Asneh Singh;Patrick Belen;Mitchell R. Kamrava;Julie K. Jang;Stephen L. Shiao;Alan C. Kwan;Cody Ramin;Raymond H. Mak;Andriana P. Nikolova;Katelyn M. Atkins - 通讯作者:
Katelyn M. Atkins
Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth emin vivo/em
- DOI:
10.1016/j.canlet.2022.215613 - 发表时间:
2022-05-28 - 期刊:
- 影响因子:10.100
- 作者:
Peibin Yue;Yinsong Zhu;Christine Brotherton-Pleiss;Wenzhen Fu;Nagendra Verma;Jasmine Chen;Kayo Nakamura;Weiliang Chen;Yue Chen;Felix Alonso-Valenteen;Simoun Mikhael;Lali Medina-Kauwe;Kathleen M. Kershaw;Maria Celeridad;Songqin Pan;Allison S. Limpert;Douglas J. Sheffler;Nicholas D.P. Cosford;Stephen L. Shiao;Marcus A. Tius;James Turkson - 通讯作者:
James Turkson
The role of concomitant chemoradiotherapy in AJCC 7<sup>th</sup> edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era
- DOI:
10.1016/j.oraloncology.2020.104882 - 发表时间:
2020-11-01 - 期刊:
- 影响因子:
- 作者:
Diana J. Lu;Michael Luu;Anthony T. Nguyen;Stephen L. Shiao;Kevin Scher;Alain Mita;Eric Anderson;Jon Mallen-St. Clair;Allen S. Ho;Zachary S. Zumsteg - 通讯作者:
Zachary S. Zumsteg
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
分泌白细胞介素-17A 的γδT 细胞通过 CX3CR1+巨噬细胞促进 HR+HER2−乳腺癌对 CDK4/CDK6 抑制剂的耐药性
- DOI:
10.1038/s43018-025-01007-z - 发表时间:
2025-07-07 - 期刊:
- 影响因子:28.500
- 作者:
Giulia Petroni;Claudia Galassi;Kenneth H. Gouin;Hsiang-Han Chen;Aitziber Buqué;Norma Bloy;Takahiro Yamazaki;Ai Sato;Manuel Beltrán-Visiedo;Ginevra Campia;Carlos Jiménez-Cortegana;Aagam Shah;Alexander Kirchmair;Chiara Massa;Claudia Wickenhauser;Carlos Eduardo de Andrea;Belén Navarro-Rubio;Irantzu Serrano-Mendioroz;Esther Navarro Manzano;Alexandra M. Satty;Brady Rippon;Francesca Finotello;Zlatko Trajanoski;Xi Kathy Zhou;Joseph M. Scandura;Elena García-Martínez;Francisco Ayala de la Peña;María Esperanza Rodríguez-Ruiz;Barbara Seliger;Víctor Sánchez-Margalet;Luis de la Cruz-Merino;Reva K. Basho;Stephen L. Shiao;Heather L. McArthur;Silvia C. Formenti;Simon R. V. Knott;Lorenzo Galluzzi - 通讯作者:
Lorenzo Galluzzi
Stephen L. Shiao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen L. Shiao', 18)}}的其他基金
Impact of the Microbiome on the Efficacy of Radiation Therapy
微生物组对放射治疗疗效的影响
- 批准号:
9767719 - 财政年份:2017
- 资助金额:
$ 35万 - 项目类别:
Impact of the Microbiome on the Efficacy of Radiation Therapy
微生物组对放射治疗疗效的影响
- 批准号:
9379354 - 财政年份:2017
- 资助金额:
$ 35万 - 项目类别:
Impact of the Microbiome on the Efficacy of Radiation Therapy
微生物组对放射治疗疗效的影响
- 批准号:
10241486 - 财政年份:2017
- 资助金额:
$ 35万 - 项目类别:
The Impact of Macrophage Polarization on the Efficacy of Radiation Therapy
巨噬细胞极化对放射治疗疗效的影响
- 批准号:
8968196 - 财政年份:2015
- 资助金额:
$ 35万 - 项目类别:
The Impact of Macrophage Polarization on the Efficacy of Radiation Therapy
巨噬细胞极化对放射治疗疗效的影响
- 批准号:
9110945 - 财政年份:2015
- 资助金额:
$ 35万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 35万 - 项目类别:
Research Grant